Bath & Body Works (NYSE:BBWI) Price Target Raised to $52.00

Bath & Body Works (NYSE:BBWI) had its target price upped by Deutsche Bank Aktiengesellschaft from $51.00 to $52.00 in a research report released on Tuesday,Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock.

Several other analysts have also commented on BBWI. Evercore ISI lowered their price target on shares of Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a research report on Wednesday, August 28th. Telsey Advisory Group reiterated an “outperform” rating and set a $42.00 target price on shares of Bath & Body Works in a report on Monday. Raymond James cut their price target on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. Barclays increased their price objective on Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a research note on Tuesday. Finally, Wells Fargo & Company boosted their target price on shares of Bath & Body Works from $32.00 to $38.00 and gave the company an “equal weight” rating in a research note on Tuesday. One research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, Bath & Body Works has a consensus rating of “Moderate Buy” and an average price target of $41.88.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $35.90 on Tuesday. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The firm has a market capitalization of $7.87 billion, a price-to-earnings ratio of 8.76, a price-to-earnings-growth ratio of 1.14 and a beta of 1.79. The stock’s fifty day moving average is $30.93 and its two-hundred day moving average is $35.65.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. As a group, sell-side analysts forecast that Bath & Body Works will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be paid a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.23%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s dividend payout ratio is currently 19.51%.

Insider Activity

In other news, CEO Gina Boswell acquired 6,000 shares of the business’s stock in a transaction dated Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. This trade represents a 2.53 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.27% of the company’s stock.

Institutional Trading of Bath & Body Works

A number of institutional investors have recently modified their holdings of the company. Anomaly Capital Management LP acquired a new stake in Bath & Body Works in the 2nd quarter valued at $113,995,000. FMR LLC boosted its position in shares of Bath & Body Works by 17,496.5% in the third quarter. FMR LLC now owns 2,516,127 shares of the company’s stock worth $80,315,000 after buying an additional 2,501,828 shares during the period. KBC Group NV grew its stake in shares of Bath & Body Works by 9,023.5% in the third quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock valued at $54,322,000 after buying an additional 1,683,160 shares in the last quarter. Erste Asset Management GmbH acquired a new stake in shares of Bath & Body Works in the third quarter valued at about $50,483,000. Finally, Lone Pine Capital LLC raised its holdings in shares of Bath & Body Works by 15.8% during the 2nd quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock valued at $441,871,000 after buying an additional 1,547,399 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.